Comparative analysis of COMT expression levels in blood and exosome-derived samples of patients with schizophrenia
Öz
Purpose: The objective of this study was to analyse the variability of COMT expression in peripheral blood and exosome samples from individuals diagnosed with schizophrenia and to establish its correlation with the drugs employed in the treatment of schizophrenia.
Materials and Methods: 45 subjects diagnosed with chronic schizophrenia were included in the patient group and 45 healthy volunteers with no family history of chronic schizophrenia were included in the control group. RNA isolation from exosome and peripheral blood was performed for each individual in the sample group. Real-time polymerase chain reaction was used to determine COMT expression levels obtained from peripheral blood and exosome samples and their association with drugs used in antipsychotic therapy was evaluated.
Results: Differential gene expression analysis was performed using the 2-ΔΔCT method. The analysis revealed an increase in COMT gene expression levels in exosome samples. Similarly, an increase in COMT expression levels was detected in peripheral blood samples. In peripheral blood samples, 31 patients exhibited an increase and 14 patients exhibited a decrease. In the exosome samples, a decrease in COMT gene expression was observed in 25 subjects, while an increase was observed in 20 subjects. A statistically significant difference was found between COMT expression levels in peripheral blood and exosome samples.
Conclusion: Investigation of alterations in COMT expression levels in schizophrenia and its treatment may provide a valuable framework for future studies to elucidate the mechanisms of this psychiatric disorder.
Anahtar Kelimeler
Schizophrenia, COMT, Exosome, RNA, Real-Time PCR
Destekleyen Kurum
Manisa Celal Bayar University
Proje Numarası
BAP 2017-218 BAP 2018-184
Kaynakça
- Stepnicki P, Kondej M, Kaczor AA. Current concepts and treatments of schizophrenia. Molecules. 2018;20:23:2087.
- Bosun A, Albu-Kalinovic R, Neda-Stepan O, Bosun I, Farcas SS, Enatescu VR et al. Dopaminergic epistases in schizophrenia. Brain Sci. 2024;14:1089.
- Chana G, Bousman CA, Money TT, Gibbons A, Gillett P, Dean B et al. Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci. 2013;7:95.
- Altıntas N, Sengöz S, Karamil S. Investigation of catechol-o-methyltransferase (COMT) Val158Met polymorphism in chronic schizophrenia diagnosed individuals in Manisa. Journal of Applied Biological Sciences. 2019;13:128-32.
- Wang Z, Xiao Z, Inslicht SS, Tong H, Jiang W, Wang X et al. Low expression of catecholamine-O-methyl-transferase gene in obsessive-compulsive disorder. J Anxiety Disord. 2009;23:660-64.
- Li Z, He Y, Han H, Zhou Y, Ma X, Wang D et al. COMT, 5-HTR2A, and SLC6A4 mRNA expressions in first-episode antipsychotic-naïve schizophrenia and association with treatment outcomes. Front Psychiatry. 2018;9:577.
- Sagud M, Tudor L, Uzun S, Perkovic MN, Zivkovic M, Konjevod M et al. Haplotypic and genotypic association of catechol-o-methyltransferase rs4680 and rs4818 polymorphisms and treatment resistance in schizophrenia. Front Pharmacol. 2018;9:705.
- Kirenskaya AV, Storozheva ZI, Gruden MA, Sewell RDE. COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 2018;268:571-84.
- Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75:807-21.
- Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L et al. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci. 2006;26:3918-22.
